SGLT2 inhibition, blood lipids, and cardiovascular disease: A Mendelian randomization study
Abstract Aims We aim to investigate the causal effect of blood lipids mediating sodium‐glucose cotransporter 2 (SGLT2) inhibition in cardiovascular disease (CVD) using Mendelian randomization (MR). Methods and results A two‐sample two‐step MR study was conducted to evaluate the association of SGLT2...
Saved in:
| Main Authors: | Jiangtao Li, Chenhe Li, Xin Feng, Xiang Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.14987 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of SGLT2 inhibitors on cardiovascular outcomes and metabolic events in Chinese han patients with chronic heart failure
by: Fei Li, et al.
Published: (2024-12-01) -
The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study
by: Bang‐Bang Huang, et al.
Published: (2024-12-01) -
SGLT2 inhibitors for alleviating heart failure through non-hypoglycemic mechanisms
by: Ya-ru Chen, et al.
Published: (2024-12-01) -
Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis
by: Chung-An Wang, et al.
Published: (2024-09-01) -
Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives
by: Kosuke Sawami, et al.
Published: (2024-11-01)